miR-21-5p is a Biomarker for Predicting Prognosis of Lung Adenocarcinoma by Regulating PIK3R1 Expression.

Jianting DuJiekun QianBin ZhengGuobing XuHao ChenChun Chen

Published in: International journal of general medicine (2021)

miR-21-5p is a potential prognostic biomarker for LUAD patients. Moreover, it might be playing a role in LUAD progression by regulating PIK3R1 expression.

Keyphrases

poor prognosis
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
binding protein
patient reported outcomes
risk assessment
climate change